Xiaoqi Liu
Corporate Officer/Principal bij Trialspark, Inc.
Profiel
Xiaoqi Liu is currently the Director & Business Development at Formation Bio Inc since 2023.
Prior to this, he worked as Director & Business Development at Halozyme Therapeutics, Inc. from 2021 to 2022 and as Director, Strategy & Corporate Development at Gelesis, Inc. from 2020 to 2021.
Liu completed his graduate degree at Northwestern University and his undergraduate degree at Beijing Normal University.
Actieve functies van Xiaoqi Liu
Bedrijven | Functie | Begin |
---|---|---|
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Corporate Officer/Principal | 01-01-2023 |
Eerdere bekende functies van Xiaoqi Liu
Bedrijven | Functie | Einde |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2022 |
GELESIS INC | Corporate Officer/Principal | 01-12-2021 |
Opleiding van Xiaoqi Liu
Northwestern University | Graduate Degree |
Beijing Normal University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Finance |
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |